06826 HAOHAI BIOTEC

Watchlist

26.700
-0.200-0.74%

Market Closed Dec 20 16:08 CST

6.25BMarket Cap13.11P/E (TTM)

About HAOHAI BIOTEC Company

The company is a scientific and technological innovation enterprise that uses biomedical materials technology and genetic engineering technology for R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. The company was listed on the main board of the Hong Kong Stock Exchange and the Science and Technology Innovation Board of the Shanghai Stock Exchange on April 30, 2015 and October 30, 2019 respectively, becoming the first “Hong Kong Stock + Science and Technology Innovation Board” biomedical listed company in the country. The Group is a technology-innovative enterprise engaged in R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. Main products: intraocular lenses, ophthalmic viscoelastic agents, corneal shaping lenses, PRL, hyaluronic acid, orthopedic joint cavity viscoelastic supplements, anti-adhesion and hemostasis, etc. The company has received honors such as the National Science and Technology Progress Award and the second prize of the National Science and Technology Progress Award.

Company Profile

Symbol06826

Company NameHAOHAI BIOTEC

ISINCNE100001W69

Listing DateApr 30, 2015

Issue Price59.00

Shares Offered40.00M share(s)

FoundedJan 24, 2007

Registered AddressChina

Chairmanyongtai hou

Secretarymingjingtianmin zhao

Audit InstitutionErnst & Young

Company CategoryMainland registration of Mainland Individuals control

Registered OfficeNo. 5 Dongjing Road, Songjiang Industrial Zone, Shanghai

Head Office and Principal Place of BusinessRoom 1901, 19th floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong

Fiscal Year Ends12-31

Employees2179

MarketHong Kong motherboard

Phone021-52293555

Fax021-52293558

Emailinfo@3healthcare.com

Websitehttp://www.3healthcare.com/

BusinessPre-licensing: hazardous chemicals management; General matters: technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion, medical research and experimental development, chemical product production (excluding licensed chemical products), chemical product sales (excluding licensed chemical products), cosmetics wholesale, cosmetics retail; general matters (registration required): Class II medical device sales, import and export of goods, technology import and export; Post-licensing: Class II medical device production, Class III medical device production, Class III medical device management, pharmaceutical production , import and export of pharmaceuticals, contract production of pharmaceuticals. (Projects requiring approval according to law can only carry out business activities after approval by the relevant departments).

Company Executives

Name
Position
Salary

yongtai hou
Presidencies, Executive Director, Strategy Committee Members, Nomination Committee Members
2.29M

jianying wu
Executive Director, General Manager, Strategy Committee Members, Remuneration Committee Members
2.46M

yiyi chen
Executive Director
1.65M

minjie tang
Executive Director, Chief Financial Officer
1.84M

jie you
Non-executive Directors, Chairman of the Strategy Committee, Audit Committee Members, Nomination Committee Members
--

ming huang
Non-executive Directors, Remuneration Committee Members, Strategy Committee Members, Authorized Representative
126.00K

zhihong jiang
Independent Non-Executive Director, Audit Committee Members
141.00K

hongbo shen
Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
--